Enliven Therapeutics Inc. (ELVN) — Net Asset Quality Index
Enliven Therapeutics Inc. (ELVN) has a Net Asset Quality Index of 97.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $464.85 Million minus total liabilities of $11.49 Million yields net assets of $453.37 Million. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Enliven Therapeutics Inc. to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Enliven Therapeutics Inc. Net Asset Quality Index Over Time (2017–2025)
This chart shows how Enliven Therapeutics Inc.'s Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the index stands at 97.5%, representing net assets of $453.37 Million against total assets of $464.85 Million USD. Explore Enliven Therapeutics Inc. (ELVN) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Enliven Therapeutics Inc. (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Enliven Therapeutics Inc. from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ELVN company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.5% | $459.49 Million | $476.17 Million | $16.68 Million | ▲ +1.4 pp |
| 2024 | 95.1% | $309.85 Million | $325.76 Million | $15.91 Million | ▲ +4.7 pp |
| 2023 | 90.5% | $245.91 Million | $271.87 Million | $25.96 Million | ▲ +182.7 pp |
| 2022 | -92.2% | $-76.83 Million | $83.30 Million | $160.12 Million | ▼ -186.5 pp |
| 2021 | 94.3% | $106.86 Million | $113.33 Million | $6.47 Million | ▲ +1.3 pp |
| 2020 | 92.9% | $84.44 Million | $90.84 Million | $6.41 Million | ▲ +6.1 pp |
| 2019 | 86.8% | $28.92 Million | $33.30 Million | $4.38 Million | ▲ +10.6 pp |
| 2018 | 76.2% | $5.87 Million | $7.71 Million | $1.83 Million | ▼ -9.2 pp |
| 2017 | 85.5% | $8.74 Million | $10.22 Million | $1.49 Million | — |